Antinuclear antibodies and oral methoxsalen photochemotherapy (PUVA) for psoriasis. 1979

R S Stern, and W L Morison, and L A Thibodeau, and R A Kleinerman, and J A Parrish, and D E Geer, and T B Fitzpatrick

In view of theoretical concern that psoralen ultraviolet A radiation (PUVA) therapy might induce a systemic lupus erythematosus-like syndrome, we studied serum antinuclear antibodies (ANAs) in patients with psoriasis who received PUVA and are participating in a five-year prospective study. At 14 centers, 1,023 patients had two or more ANA determinations. When first and last tests were compared, the incidence of positive tests for ANAs was not significantly different (P greater than .2). In addition, there was no apparent relationship between the frequency of PUVA treatments and the probability of a positive test. Over a two-year period, there is no evidence to indicate that PUVA therapy for psoriasis has resulted in a significantly higher number of positive tests for ANAs within our population.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008730 Methoxsalen A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation. 8-Methoxypsoralen,Ammoidin,Xanthotoxin,8-MOP,Deltasoralen,Dermox,Geroxalen,Meladinina,Meladinine,Meloxine,Methoxa-Dome,Méladinine,Oxsoralen,Oxsoralen-Ultra,Puvalen,Ultramop,8 MOP,8 Methoxypsoralen,8MOP,Methoxa Dome,Oxsoralen Ultra
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females

Related Publications

R S Stern, and W L Morison, and L A Thibodeau, and R A Kleinerman, and J A Parrish, and D E Geer, and T B Fitzpatrick
August 1981, Archives of dermatology,
R S Stern, and W L Morison, and L A Thibodeau, and R A Kleinerman, and J A Parrish, and D E Geer, and T B Fitzpatrick
September 1980, Journal of the American Academy of Dermatology,
R S Stern, and W L Morison, and L A Thibodeau, and R A Kleinerman, and J A Parrish, and D E Geer, and T B Fitzpatrick
January 1981, Acta dermato-venereologica,
R S Stern, and W L Morison, and L A Thibodeau, and R A Kleinerman, and J A Parrish, and D E Geer, and T B Fitzpatrick
July 1981, American journal of hospital pharmacy,
R S Stern, and W L Morison, and L A Thibodeau, and R A Kleinerman, and J A Parrish, and D E Geer, and T B Fitzpatrick
September 1980, International journal of dermatology,
R S Stern, and W L Morison, and L A Thibodeau, and R A Kleinerman, and J A Parrish, and D E Geer, and T B Fitzpatrick
January 1981, The Journal of the Kentucky Medical Association,
R S Stern, and W L Morison, and L A Thibodeau, and R A Kleinerman, and J A Parrish, and D E Geer, and T B Fitzpatrick
December 1974, The New England journal of medicine,
R S Stern, and W L Morison, and L A Thibodeau, and R A Kleinerman, and J A Parrish, and D E Geer, and T B Fitzpatrick
January 1985, Acta dermato-venereologica,
R S Stern, and W L Morison, and L A Thibodeau, and R A Kleinerman, and J A Parrish, and D E Geer, and T B Fitzpatrick
July 1976, Archives of dermatology,
R S Stern, and W L Morison, and L A Thibodeau, and R A Kleinerman, and J A Parrish, and D E Geer, and T B Fitzpatrick
June 1976, The Journal of the American Osteopathic Association,
Copied contents to your clipboard!